Balanced news tone
News Sentiment
GLENMARK sentiment intelligence
Glenmark Pharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
59
Balanced news tone
32 relevant articles
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
+1.8% over one week, -2.0% over four weeks, trend active, and materially above fair value.
Glenmark Stock - analyst consensus and valuation snapshot
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
78/100 classification
One-week reaction
1.8%
Price digesting
Trend fit
Trend active
-2.0% over four weeks
Fair value
49.2%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
11
Neutral
21
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
AD HOC NEWS
Direct company coverage
Glenmark Stock - analyst consensus and valuation snapshot
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 21 Jun 2026 20:38
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Glenmark Stock - analyst consensus and outlook midyear
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 17 Jun 2026 19:49
- Source
- AD HOC NEWS
scanx.trade
Direct company coverage
Glenmark launches Methylene Blue Injection in US market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 04:17
- Source
- scanx.trade
Business Standard
Direct company coverage
Glenmark Pharmaceuticals launches Winlevi across key European markets
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Business Standard
NDTV Profit
Direct company coverage
Glenmark Pharma Profit Expected To Soar 5x in Two Years, Says Motilal Oswal — Check Target Price
- Tone
- Positive 74/100
- Event
- Earnings
- Published
- 10 Jun 2026 07:00
- Source
- NDTV Profit
simplywall.st
Direct company coverage
We Think Glenmark Pharmaceuticals' (NSE:GLENMARK) Healthy Earnings Might Be Conservative
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 Jun 2026 07:00
- Source
- simplywall.st
HDFC Sky
Direct company coverage
Glenmark Launches Lacosamide Injection; Shares Rise 1%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- HDFC Sky
Moneycontrol.com
Direct company coverage
Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 02 Jun 2026 07:00
- Source
- Moneycontrol.com
simplywall.st
Direct company coverage
Is Now The Time To Put Glenmark Pharmaceuticals (NSE:GLENMARK) On Your Watchlist?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- simplywall.st
CNBC TV18
Direct company coverage
Stocks to Watch for June 1: IndiGo, Glenmark Pharma, Lupin, NMDC, textile stocks and more
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 May 2026 07:00
- Source
- CNBC TV18
NDTV Profit
Direct company coverage
Glenmark Pharma Q4 Result: Net Profit Soars 64 Times, Revenue Rises; Dividend Declared
- Tone
- Positive 74/100
- Event
- Earnings
- Published
- 29 May 2026 07:00
- Source
- NDTV Profit
CNBC TV18
Direct company coverage
Glenmark Pharma Q4 net profit zooms to ₹301 crore; recommends 250% dividend
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 29 May 2026 07:00
- Source
- CNBC TV18
scanx.trade
Direct company coverage
Glenmark to host Annual Investor Day 2026 on June 9
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- scanx.trade
AD HOC NEWS
Direct company coverage
Glenmark Pharmaceuticals stock (INE935A01035): shares under pressure on NSE India as investors track
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- AD HOC NEWS
Moneycontrol.com
Direct company coverage
Stocks to Watch Today: TVS Motor, Exide Industries, Meesho, Groww, Gujarat Themis, Glenmark Pharma,...
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- Moneycontrol.com
HDFC Sky
Direct company coverage
Glenmark Launches Vancomycin Injection; Shares Dip 0.36%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- HDFC Sky
Business Standard
Direct company coverage
Glenmark Pharmaceuticals Ltd slips for fifth straight session
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- Business Standard
AD HOC NEWS
Direct company coverage
Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 11 May 2026 07:00
- Source
- AD HOC NEWS
Business Standard
Direct company coverage
Nifty eyes 24,600; SBI, Glenmark Pharma, Tata Power on analyst radar
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 16 Apr 2026 07:00
- Source
- Business Standard
The Economic Times
Direct company coverage
Glenmark Pharma may outperform amid market correction; technicals turn positive: Ruchit Jain
- Tone
- Positive 82/100
- Event
- Analyst action
- Published
- 24 Mar 2026 07:00
- Source
- The Economic Times
Moneycontrol.com
Direct company coverage
Trade Spotlight: How should you trade Avenue Supermarts, Glenmark, Bharat Dynamics, Torrent Pharma,...
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Mar 2026 07:00
- Source
- Moneycontrol.com
CNBC TV18
Direct company coverage
Glenmark Pharma Q3: Profit, revenue up over 15% as India, North America drive growth
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 30 Jan 2026 08:00
- Source
- CNBC TV18
The Economic Times
Direct company coverage
Glenmark Q3 profit rises 16% on strong India, US performance
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 30 Jan 2026 08:00
- Source
- The Economic Times
Business Standard
Direct company coverage
Glenmark Q3 profit rises 15% on strong market performance; Revenue up 15%
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 30 Jan 2026 08:00
- Source
- Business Standard
Business Standard
Direct company coverage
Glenmark Pharma stock gains 3% on launch novel COPD treatment; details here
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 Nov 2025 08:00
- Source
- Business Standard
simplywall.st
Direct company coverage
Glenmark Pharmaceuticals Limited Just Beat Revenue By 16%: Here's What Analysts Think Will Happen Next
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 19 Nov 2025 08:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Getting In Cheap On Glenmark Pharmaceuticals Limited (NSE:GLENMARK) Might Be Difficult
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Nov 2025 08:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Here's Why Glenmark Pharmaceuticals Limited's (NSE:GLENMARK) CEO Compensation Is The Least Of Shareholders' Concerns
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Sep 2025 07:00
- Source
- simplywall.st
Business Standard
Direct company coverage
Glenmark Pharma shares rise as arm receives an upfront payment of $700 mn
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Sep 2025 07:00
- Source
- Business Standard
Business Standard
Direct company coverage
Glenmark Pharma up 3% on DCGI nod to start phase 3 trial of Envafolimab
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Sep 2025 07:00
- Source
- Business Standard